The fate of infected macrophages has an essential role in protection against Mycobacterium tuberculosis by regulating innate and adaptive immunity. M. tuberculosis exploits cell necrosis to exit from macrophages and spread. In contrast, apoptosis, which is characterized by an intact plasma membrane, is an innate mechanism that results in lower bacterial viability. Virulent M. tuberculosis inhibits apoptosis and promotes necrotic cell death by inhibiting production of prostaglandin E 2 . Here we show that by activating the 5-lipoxygenase pathway, M. tuberculosis not only inhibited apoptosis but also prevented cross-presentation of its antigens by dendritic cells, which impeded the initiation of T cell immunity. Our results explain why T cell priming in response to M. tuberculosis is delayed and emphasize the importance of early immunity.
Mycobacterium tuberculosis is one of the most important bacterial pathogens 1 . The ability of M. tuberculosis to persist in people with apparently normal immune systems indicates that M. tuberculosis has developed strategies to avoid, evade and even subvert innate and adaptive immunity 2 . Although macrophages excel at destroying the biological particles they engulf by phagocytosis, which include dead cells and bacteria, M. tuberculosis has evolved into a para site of the intracellular milieu of macrophages, where it not only survives but also replicates in the naturally hostile environment of the phagosome 3, 4 . Intracellular pathogens such as M. tuberculosis have developed complex and multifactorial mechanisms by which to evade host defenses. One important strategy used by intra cellular pathogens is subversion of the host cell's death pathways 5 . Several intracellular pathogens, including Leishmania, Coxiella, Salmonella, Chlamydia and Yersinia, induce hostcell apoptosis as a way of minimizing the inflammatory response and avoid detec tion [6] [7] [8] . In some of these cases, the induction of hostcell necrosis, sometimes by pyroptosis, leads to lower bacterial viability and is beneficial to the host 9, 10 . Other acute bacterial pathogens, such as Pseudomonas, Neisseria and Streptococcus, are cleared by hostcell apoptosis, and these pathogens evade innate immunity by inhibit ing apoptosis 11 . Virulent strains of M. tuberculosis induce necrosis of both human and mouse macrophages, whereas attenuated M. tuberculosis strains or other nonpathogenic mycobacterial species generally do not [12] [13] [14] . Virulent M. tuberculosis actively inhibits the induction of macrophage apoptosis 15 , consistent with the identification of M. tuberculosis mutants that induce apoptosis instead of necrosis 16, 17 . In addition, there is accumulating evidence that apoptosis, whether induced by the pathogen itself 18, 19 , pharmaco logically 20 or by cytotoxic lymphocytes 21, 22 , results in lower viability of M. tuberculosis.
One strategy used by M. tuberculosis to avoid apoptosis is the sub version of host eicosanoid biosynthetic pathways. The attenuated M. tuberculosis strain H37Ra induces the production of prostaglandin E 2 (PGE 2 ), which protects the mitochondrial inner membrane and induces the repair of plasma membrane microdisruptions inflicted by the pathogen 12, 13 . These events protect the host macrophages against necrosis and instead promote apoptosis. In contrast, intra cellular infection with the virulent H37Rv strain of M. tuberculosis induces the production of lipoxin A 4 (LXA 4 ), which inhibits cyclooxy genase 2 production and PGE 2 biosynthesis 12, 13 . In a PGE 2 poor microenvironment, macrophages cannot prevent the mitochon drial damage or repair the plasma membrane disruptions caused by M. tuberculosis, and this leads to necrosis 12, 13 . Virulent M. tuberculosis in prenecrotic macrophages continues to replicate and to spread to uninfected macrophages after the cells are lysed. Thus, the balance of PGE 2 and LXA 4 regulates the relative amounts of apoptosis and necrosis after M. tuberculosis infection, with important functional consequences for innate control of the intracellular infection. The essential role of these host lipid pathways in innate immunity has been confirmed by genetic analysis of the susceptibility of zebrafish to Mycobacterium marinum 23 .
The crosstalk between innate immunity and adaptive immunity in response to intracellular infection is essential, particularly in the case of pathogens that infect macrophages. This is certainly true for immunity to M. tuberculosis, which requires complex synchronization and cooperation between the various arms of the immune system. The regulation of cell death during M. tuberculosis infection should be considered in this context because as well as limiting bacterial replica tion, apoptotic macrophages seem to provide an important bridge to adaptive immunity. Dendritic cells (DCs) can acquire viral or bacterial antigens through the uptake of apoptotic vesicles derived from A r t i c l e s infected macrophages [24] [25] [26] . Crosspresentation, initially described in the context of viral infection 26 , seems to occur during M. tuberculosis infection and to be important for priming of CD8 + T cell responses. For example, the secA2 mutant of M. tuberculosis, which induces more apoptosis of infected macrophages in vitro and in vivo, is associated with enhanced antigenspecific CD8 + T cell immunity, presumably as a consequence of more crosspriming 16, 27 . Furthermore, purified apoptotic vesicles derived from bacillus CalmetteGuérin (BCG) infected macrophages that are free of any viable bacteria can transfer mycobacterial antigens to human DCs, which can crosspresent the antigens to human CD8 + and CD1restricted T cells 28 . Similarly, vaccination of mice with purified apoptotic vesicles is sufficient to stimulate T cell immunity against the mycobacterial antigen cargo contained in the vesicles and to elicit protective immunity to challenge with virulent M. tuberculosis 29 .
The microbiological and immunological data outlined above support the 'detour' model 30 , in which apoptotic blebs derived from cells infected with intracellular pathogens facilitate crosspresentation of microbial antigens to CD8 + T cells. However, it is not known whether apopto sis of infected macrophages occurs in vivo and, if so, whether it has physiological importance. Because the supporting studies used apop totic vesicles derived from BCGinfected macrophages 28, 29 , it remains unclear whether infection of macrophages with wildtype virulent M. tuberculosis would lead to apoptosis and enhanced T cell immunity or whether virulent M. tuberculosis prevents presentation of its anti gens and inhibits initiation of adaptive immunity by other mechanisms. Finally, although immunization with purified apoptotic vesicles leads to crosspriming of antigenspecific T cells by DCs, it is not known whether the same mechanism occurs after infection with M. tuberculosis in vivo. Lowdose aerosol infection in mice is characterized by a delay in the initiation of T cell immunity 31, 32 , but it is unclear whether this delay is due to the inhibition of macrophage apoptosis by virulent M. tuberculosis. Although DCs are required to generate antigenspecific T cell responses 33 , DCs can be directly infected by M. tuberculosis 34, 35 . M. tuberculosis-infected DCs in the lung traffic to the regional lymph node with kinetics that mirror those of T cell priming, consistent with the idea that M. tuberculosis-infected DCs prime M. tuberculosisspecific T cells directly. This indicates that there might be a priming pathway independent of the 'detour' pathway 31, 32, 34 . Thus, the role of apoptosis and crosspriming in the generation of adaptive immunity during virulent M. tuberculosis infection remains unclear.
Macrophages from mice deficient in 5lipoxygenase (Alox5 −/− mice), which cannot synthesize LXA 4, undergo more apoptosis after infection with virulent M. tuberculosis 12, 13 . Conversely, macrophages that lack prostaglandin E synthase (Ptges −/− mice), which cannot pro duce PGE 2 , undergo more necrosis after infection, even with avirulent M. tuberculosis strains. The greater resistance of Alox5 −/− mice 36 and the greater susceptibility of Ptges −/− mice 13 to infection with virulent M. tuberculosis led us to hypothesize that apoptosis and its regulation by eicosanoids are key determinants of innate and adaptive host resist ance to infection. We have developed an adoptivetransfer model using M. tuberculosis-infected macrophages to determine whether inhibi tion of apoptosis by virulent M. tuberculosis leads to less crosspriming by DCs and to impaired T cell immunity. We find that by inhibiting apoptosis, virulent M. tuberculosis downregulated crosspresentation of M. tuberculosis antigens and impaired T cell responses. 36 . To establish that the larger amounts of IL12, IFNγ and iNOS in Alox5 −/− mice infected with M. tuberculosis correlate with enhanced T cell immunity, we quantified the antigenspecific T cell response in wildtype, Ptges −/− and Alox5 −/− mice after aerosol infection with viru lent M. tuberculosis. At 2 weeks after infection, the CD8 + T cell response to the immunodominant antigen TB10.4 was greater in the draining lymph nodes of Alox5 −/− mice than in those of Ptges −/− or wildtype mice (Fig. 1a) . The frequency of TB10.4specific CD8 + T cells was significantly higher (14%) in the lungs of Alox5 −/− mice infected with M. tuberculosis than in those of Ptges −/− mice (4%) or wildtype (5%) mice (Fig. 1b) . Moreover, splenic T cells from infected Alox5 −/− mice produced more IFNγ after being stimulated with M. tuberculosis cul turefiltrate proteins TB10.4(4-11) (a peptide of amino acids 4-11 of TB10.4, specific for CD8 + T cells) or Ag85B(241-256) (a peptide of amino acids 241-256 of Ag85B, specific for CD4 + T cells) than did cells from infected Ptges −/− or wildtype mice (data not shown). Kinetic analysis of the TB10.4specific CD8 + T cell response indicated that the response in the Alox5 −/− mice was earlier than that of wildtype or Ptges −/− mice (Fig. 1c) . At 5 weeks after infection, the M. tuberculosis antigen-specific CD8 + T cell response in the lung and spleen was similar in the various experimental groups, although the lung bac terial burden was significantly higher in Ptges −/− mice and lower in Alox5 −/− mice than in wildtype mice (P < 0.05; Supplementary Fig. 1 ).
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This observation emphasizes the importance of early T cell immunity in protection against M. tuberculosis infection. Collectively, these data show that after M. tuberculosis infection, the CD4 + and CD8 + T cell response to M. tuberculosis was earlier and stronger in Alox5 −/− mice than in either wildtype mice or Ptges −/− mice. Thus, LXA 4 negatively regulates T cell immunity to tuberculosis.
Alox5 −/− macrophages enhance CD8 + T cell responses
To determine whether the enhanced T cell response in Alox5 −/− mice was due to an intrinsic property of Alox5 −/− T cells, we transferred splenic T cells from wildtype, Ptges −/− or Alox5 −/− mice infected with M. tuberculosis into sublethally irradiated wildtype mice 37, 38 . At 1 d after T cell transfer, we infected the recipient mice with virulent M. tuberculosis by aerosol. Three weeks later, we detected no difference in colonyforming units (CFU) in the lungs ( Supplementary Fig. 2 ) or spleens (data not shown) of the mice. Thus, the T cells of these mice had similar intrinsic capacity to protect against pulmonary infection with M. tuberculosis.
Because we found a greater T cell response early after infection in Alox5 −/− mice, we hypothesized that the initiation of T cell immunity differed in Alox5 −/− versus wildtype mice. To study the early events of T cell priming and to determine whether eicosanoids modulate initiation of T cell immunity, we developed an adoptivetransfer model using M. tuberculosis-infected macrophages. The model allows specific analysis of how lipid mediators produced by macrophages infected with M. tuberculosis affect T cell-mediated immunity independently of other eicosanoidproducing cell types.
We measured the migration of uninfected CD45.2 + macrophages in the airways and lung tissues at various time points after intratracheal adoptive transfer of these cells into CD45.1 + congenic mice. We detected the transferred macrophages for at least 7 d ( Supplementary  Fig. 3 ), which indicated that these cells can migrate into the lung tissue and persist. We next infected wildtype, Ptges −/− and Alox5 −/− macrophages in vitro with M. tuberculosis using a low multiplicity of infection. We transferred the infected macrophages by the intra tracheal route into wildtype recipient mice. We found that 17 d later, there were significantly more TB10.4specific CD8 + T cells in both the thoracic draining lymph node and the lungs of mice that received M. tuberculosis-infected Alox5 −/− macrophages than in those of mice that received M. tuberculosis-infected wildtype or Ptges −/− macro phages (Fig. 2a) . Lymphocytes from the thoracic lymph nodes and lungs of mice that received M. tuberculosisinfected Alox5 −/− macro phages also secreted more IFNγ after stimulation with M. tuberculosis antigens recognized by CD8 + T cells (TB10.4(4-11) and 32c(309-318)) or CD4 + T cells (Ag85B(241-256) and ESAT6(3-15); Fig. 2b) . The enhanced T cell response after adoptive transfer of Alox5 −/− macro phages seemed to be the result of earlier initiation of the immune response, just as observed for intact Alox5 −/− mice (Fig. 1c) . We detected the TB10.4specific CD8 + T cell response earlier in the pulmo nary draining lymph nodes and the lungs of the recipient mice after adoptive transfer of M. tuberculosisinfected Alox5 −/− macrophages than after wildtype macrophage transfer (Fig. 2c) . Moreover, 4 weeks after adoptive transfer, the pulmonary bacterial burden was lower in wildtype mice that had received infected Alox5 −/− macrophages than in mice that had received infected wildtype or Ptges −/− macrophages ( Fig. 2d) . At this time point, the number of TB10.4specific CD8 + T cells in the lung and spleen was similar in the groups ( Supplementary  Fig. 4 ), which suggested that the early initiation of T cell immunity contributes substantially to protection against M. tuberculosis. The ability to recapitulate the early T cell response and lower pulmonary bacterial burden of Alox5 −/− mice produced solely by transfer of M. tuberculosis-infected Alox5 −/− macrophages into unmanipulated mice shows the important influence of eicosanoid production by infected macrophages on the regulation of T cell immunity and host resistance to pulmonary M. tuberculosis infection. Thus, the predomi nant production of PGE 2 by infected Alox5 −/− macrophages, which in vitro is the cause of more apoptosis, correlates with a greater T cell response during the early phase of infection in vivo.
Alox5 −/− alveolar macrophages enhance T cell responses We next investigated whether transfer of infected alveolar Alox5 −/− macrophages elicited an increased pulmonary T cell response. We obtained minimally manipulated infected alveolar macrophages by bronchoalveolar lavage 3 h after infection of wildtype or Alox5 −/− mice. We transferred the lavaged cells into naive wildtype mice via the intratracheal route. On day 17 after transfer of alveolar macro phages, we detected no TB10.4specific CD8 + T cells in the lungs, pul monary lymph nodes (PLNs) or spleens of mice that received infected wildtype alveolar macrophages (Fig. 3a) . In contrast, we identified TB10.4specific CD8 + T cells in all three tissues in mice that received infected Alox5 −/− alveolar macrophages. The percentage of CD8 + T cells specific for TB10.4(4-11) was significantly higher in the lungs and PLNs of mice that received infected Alox5 −/− alveolar macro phages than that in those of recipients of wildtype alveolar macro phages (Fig. 3b) .
We measured the frequency of IFNγsecreting T cells in lympho cytes from lungs, PLNs and spleens of recipient mice stimulated with TB10.4(4-11) or 32c(309-318) (CD8 + epitopes) or with Ag85B(241-256) or ESAT6(3-15) (CD4 + epitopes). As noted after transfer of peritoneal macrophages (Fig. 2b) , we detected a greater T cell response encompassing both CD4 + and CD8 + T cells after the transfer of infected Alox5 −/− alveolar macrophages than after the transfer of wildtype alveolar macrophages ( Supplementary  Fig. 5 ). Thus, similar to results obtained with thioglycollate elicited peritoneal macrophages, the dysregulated production of prostanoids by alveolar macrophages is associated with the initia tion of an earlier CD4 + and CD8 + T cell response.
Alox5 −/− macrophages enhance CD8 + T cell cross-priming We considered two potential mechanisms by which infected macro phages might affect T cell immunity: first, Alox5 −/− macrophages could directly prime naive T cells; and second, macrophage cell death could affect the crosspresentation of M. tuberculosis antigens by DCs. We first evaluated whether Alox5 −/− macrophages have a greater ability than other macrophages to stimulate M. tuberculosis-specific T cells in vitro. We pulsed wildtype, Ptges −/− and Alox5 −/− macrophages with total M. tuberculosis antigens (M. tuberculosis sonicate), intact Ag85 protein or Ag85B(241-256) and found no difference in their ability to stimulate IL2 production by the Ag85B specific T cell hybridoma BB7 39 ( Supplementary Fig. 6) ; this indicated that the intrinsic ability of these macrophages to process and present antigen was unaffected by PGE 2 synthase or 5lipoxygenase.
To determine how infected Alox5 −/− macrophages elicit an enhanced T cell response, we evaluated the ability of M. tuberculosis-infected macrophages to prime CD8 + T cells. We used OTI T cell antigen receptor-transgenic CD8 + T cells that were specific for the ovalbu min (OVA) epitope SIINFEKL and expressed the CD90.2 congenic T cell marker. We labeled these cells with the cytosolic dye CFSE (car boxyfluorescein diacetate succinimidylester) and transferred them into CD90.1 + congenic recipient mice. Then, 1 d later, we injected wildtype, Ptges −/− or Alox5 −/− macrophages pulsed with SIINFEKL peptide and infected with M. tuberculosis into the footpads of wild type mice. We analyzed T cells in the draining popliteal lymph nodes 4 d later. The proliferation and population expansion of OTI T cells were significantly greater after the administration of M. tuberculosis infected SIINFEKLpulsed Alox5 −/− macrophages than after adminis tration of similarly treated wildtype macrophages (Fig. 4a,b) . After transfer of wildtype macrophages that had been pulsed with peptide and infected with M. tuberculosis, we detected only a small popula tion of SIINFEKLspecific CD8 + T cells (~500 cells per lymph node). This was not substantially different from the number found in mice that received only OTI cells, without macrophages. In contrast, we found an expanded population of OVAspecific T cells after transfer of Alox5 −/− macrophages that had been pulsed with SIINFEKL and infected with M. tuberculosis (~1 × 10 4 cells per lymph node; 20fold more than after transfer of wildtype macrophages treated similarly). 
A r t i c l e s
We found no difference in OTI T cell proliferation after the adminis tration of wildtype or Ptges −/− macrophages (data not shown).
Although the transfer of infected Alox5 −/− macrophages elicited a greater OTI response than did the transfer of wildtype cells, we found no difference in OTI T cell proliferation after the transfer of unin fected, SIINFEKLpulsed Alox5 −/− or wildtype macrophages, with or without lipopolysaccharide (Supplementary Fig. 7 ). In addition, the transfer of uninfected, SIINFEKLpulsed Alox5 −/− or wildtype macrophages that had been treated with the apoptosisinducing agent staurosporine poorly stimulated OTI proliferation ( Supplementary  Fig. 7 ). These data confirm that there is no intrinsic difference between Alox5 −/− and wildtype macrophages in their ability to stimulate T cell responses and instead support the idea that the greater apoptosis of M. tuberculosisinfected Alox5 −/− macrophages leads to more T cell priming than do wildtype or Ptges −/− macrophages.
We next investigated whether the enhanced capacity of Alox5 −/− macrophages to prime antigenspecific T cells was due to direct pres entation by the M. tuberculosis-infected Alox5 −/− macrophages or required crosspriming by DCs. We transferred infected macrophages and OTI T cells into transgenic mice that expressed the diphtheria toxin receptor (DTR) fused to green fluorescent protein (GFP) under the control of the CD11c promoter (B6.FVBTgItgaxDTR/EGFP 57Lan/J, CD11cDTR-transgenic mice). Administration of diphtheria toxin results in transient deletion of CD11c + antigenpresenting cells (APCs; Supplementary Fig. 8 ). We adoptively transferred CFSE labeled OTI T cells into CD11cDTR-transgenic mice and their non transgenic littermates. After 24 h, we treated the mice with diphtheria toxin and transferred SIINFEKLpulsed, M. tuberculosis-infected Alox5 −/− macrophages into them. The transfer of SIINFEKLpulsed, infected Alox5 −/− macrophages into nontransgenic littermate controls treated with diphtheria toxin induced significant T cell population expansion in the popliteal lymph nodes 4 d after transfer, as described above (Fig. 4c) . However, when we transferred SIINFEKLpulsed, M. tuberculosis-infected Alox5 −/− macrophages into CD11cDTR-transgenic mice treated with diphtheria toxin, we found only a small population of OTI cells. This population was not significantly different from that in mice that had not received Alox5 −/− macrophages (Fig. 4c) . Both the percentage and the total number of CD8 + T cells specific for SIINFEKL were much smaller after deletion of CD11c + APCs (Fig. 4c) , which indicated that the transferred Alox5 −/− macrophages were not sufficient to prime CD8 + T cells and that endogenous CD11c + DCs were required.
To further investigate whether crosspriming was required for the response described above, we transferred CFSElabeled OTI T cells into mice deficient in TAP1, the transporter associated with antigen processing, or into mice deficient in β 2 microglobulin, which lack mature major histocompatibility complex (MHC) class I molecules. In the absence of TAP1 or β 2 microglobulin in recipient mice, OTI T cell populations did not expand after transfer of SIINFEKLpulsed, M. tuberculosis-infected Alox5 −/− macrophages. This observation shows that the population expansion of OTI T cells after transfer of infected Alox5 −/− macrophages depended on the processing and presen tation of SIINFEKL by the hostderived MHC class I pathway (Fig. 4d) . Collectively, these data indicate that M. tuberculosis-infected Alox5 −/− macrophages enhance CD8 + T cell responses through DCdependent crosspriming.
Macrophage apoptosis enhances T cell immunity
We next tested whether inhibition of apoptosis would reverse the greater T cell immunity seen after transfer of M. tuberculosis-infected Alox5 −/− macrophages. Infection of Alox5 −/− macrophages with the virulent H37Rv strain of M. tuberculosis led to apoptosis, as reported before 12 . The apoptosis of M. tuberculosis-infected Alox5 −/− macrophages was significantly inhibited in vitro by an inhibitor of caspase 8 and the extrinsic apoptotic pathway, by an inhibitor of caspase9 and the intrinsic apoptotic pathway, and by a combination of both inhibitors (Fig. 5a) .
We postulated that DC uptake and crosspresentation of the antigen cargo contained in apoptotic vesicles derived from M. tuberculosis-infected Alox5 −/− macrophages augments the T cell response in vivo. To test this possibility, we treated M. tuberculosis-infected Alox5 −/− macro phages with the inhibitors of caspase8 and caspase9 described above or with an inactive caspaseinhibitor control and subsequently transferred the cells by the intratracheal route into the lungs of uninfected wildtype mice. As expected, the transfer of M. tuberculosis-infected Alox5 −/− macrophages treated with the A r t i c l e s negative control peptide augmented the TB10.4specific CD8 + T cell response, as described above (Fig. 5b) . In contrast, the trans fer of M. tuberculosis-infected Alox5 −/− macrophages treated with inhibitors of caspase8 and caspase9 did not induce early popula tion expansion of TB10.4specific CD8 + T cells in the lung (Fig. 5b) . Thus, apoptosis of M. tuberculosisinfected macrophages is required for the early initiation of T cell immunity after pulmonary infection with M. tuberculosis.
DISCUSSION
Pulmonary macrophages are the primary hosts for the replication of M. tuberculosis. The ability of M. tuberculosis to inhibit macrophage antimicrobial defenses makes it a successful pathogen. The induc tion of apoptosis, including formation of the apoptotic envelope, is inhibited in macrophages infected with virulent M. tuberculosis 14, 40, 41 . PGE 2 can prevent necrosis of M. tuberculosis-infected macrophages by protecting against mitochondrial inner membrane instability and promoting the repair of plasma membrane damage, two independent insults induced by virulent M. tuberculosis 12, 13 . By preventing necrosis and increasing apoptosis of M. tuberculosis-infected macrophages, PGE 2 enhances innate immune control of the initial infection both in vitro and in vivo 12 . Here we have used an adoptivetransfer model in which macrophages were infected in vitro with M. tuberculosis and then transferred into recipient mice to address whether apoptotic macrophages contribute to the initiation of adaptive immunity. We found that the host lipid mediator PGE 2 was required for the induction of apoptosis in M. tuberculosis-infected macrophages, which in turn promoted T cell priming in vivo. An enhanced antigenspecific CD8 + T cell response required presentation of apoptotic macrophagederived antigens by the 'detour' pathway, as defined by the TAP1dependent and MHC class I-restricted crosspresentation by DCs. In addition to CD8 + T cell responses, CD4 + T cell responses were also consid erably enhanced after the transfer of proapoptotic M. tuberculosisinfected macrophages. We have shown that the adoptive transfer of proapoptotic M. tuberculosis-infected macrophages led to an early and robust antigenspecific T cell response that correlated with considerable pulmonary protection. Thus, virulent M. tuberculosis inhibits PGE 2 production and prevents macrophage apoptosis, which impairs both innate and adaptive immunity to M. tuberculosis. One way that M. tuberculosis evades host defense mechanisms is by delaying the initiation of T cell priming 31, 32 . There is a longer delay between M. tuberculosis infection and the initiation of adaptive immunity than for other intracellular pathogens, including Salmonella enteritica 42 , Listeria monocytogenes 43 , Leishmania major 44 Understanding how cellular death affects innate and adaptive immunity is important for elucidating disease pathogenesis. In non infectious diseases such as autoimmunity, cell death through necrosis enhances T cell-mediated immunity to specific antigens because loss of plasmamembrane integrity and release of the cellular contents acts as an adjuvant. In contrast, apoptosis might prevent autoimmu nity because apoptotic cells maintain the integrity of their cell mem branes and are rapidly removed by phagocytes 47 . During infection with M. tuberculosis, cellular necrosis and loss of plasma membrane integrity allow bacteria to infect other cells 12 , whereas apoptosis of M. tuberculosis-infected cells enhances the innate control of intra cellular bacterial replication as well as T cell-mediated immunity. Published studies have emphasized the importance of apoptosis in the crosspresentation of M. tuberculosis antigens by human DCs in vitro and the role of apoptotic vesicles purified from BCGinfected macrophages in vivo 16, 29 . However, the response of host macrophages to live M. tuberculosis in vivo has not been addressed.
We developed an infected macrophage adoptivetransfer model that allows study of how altering macrophage function in an other wise normal host affects immunity to M. tuberculosis. Just as infec tion with proapoptotic bacterial mutants generates greater CD8 + T cell responses 16 , a propensity for the host macrophage to undergo apoptosis also enhanced T cell immunity and led to better protection. Enhanced T cell-mediated immunity was not restricted to CD8 + T cells. M. tuberculosis-specific CD4 + responses were also greater after the transfer of infected proapoptotic Alox5 −/− macrophages. Thus, whereas apoptosis directly increased CD8 + T cell responses by crosspresentation, it also enhanced MHC class II-restricted antigen presentation. Presumably, phagocytosis of apoptotic vesicles by DCs delivers their M. tuberculosis antigen cargo to the endocytic system, which intersects with the MHC class II processing pathway, ultimately increasing the priming of CD4 + T cells.
Whereas DCs are required for priming mycobacterial specific T cell immunity 33 , the demonstration that DCs are directly infected by M. tuberculosis and facilitate the local dissemination of M. tuberculosis to regional lymph nodes 34 suggests that M. tuberculosis-infected DCs might be crucial for T cell priming. Our finding that intratracheal transfer of alveolar or peritoneal M. tuberculosis-infected Alox5 −/− macrophages led to earlier initiation of CD4 + and CD8 + T cell immunity suggests that the transfer of antigen to uninfected DCs is sufficient for T cell priming. The thioglycollateelicited peritoneal macrophages used in our study here were activated and recruited into the peritoneal space, just as most macrophages found in the lungs of infected mice were recruited from the periphery. Because peritoneal macrophages can directly prime CD8 + T cells in vivo 48 , we determined whether M. tuberculosis-infected macrophages directly prime T cells or whether their propensity to undergo apoptosis leads to the entry of mycobacterial antigens into the detour pathway. We found that infected Alox5 −/− macrophages could not directly prime T cells and instead that T cell priming required endogenous DCs. A limitation of the CD11cDTR model is macrophage toxicity owing to ingestion of diphtheria toxin from dying DCs, which can mask macrophage priming of T cells 49 . However, by using mice deficient in TAP1 or β 2 microglobulin as recipients, we have demonstrated the importance of the endogenous MHC class I processing and presentation pathway. Similar to results obtained with DC depletion, we did not observe OTI T cell population expansion when we administered proapoptotic M. tuberculosis-infected Alox5 −/− macrophages to mice deficient in TAP1 or β 2 microglobulin. These experiments showed that CD8 + T cell priming required crosspresentation of antigens acquired by DCs from apoptotic, M. tuberculosis-infected macrophages through the detour pathway.
Finally, we speculate that the proinflammatory function of apop tosis during infection, in contrast to its antiinflammatory pro pensity during physiological cell death, might be a consequence of Tolllike receptor ligands and other microbederived signals that are contained in the apoptotic vesicles. Our data indicate that Alox5 −/− macrophages are not intrinsically more stimulatory than are wildtype macrophages, as cells of both genotypes processed and presented antigen to T cells in vitro and in vivo with similar efficiency. Instead, we found that apoptosis under proinflammatory conditions led to more efficient crosspriming. These results are in keeping with the idea that apoptotic cells do not stimulate primary immune responses unless there are additional danger signals, such as infection, that lead to inflammation by triggering Tolllike receptor or other pattern recognition receptor signaling.
Despite the worldwide application of BCG vaccination and other anti-M. tuberculosis interventions, M. tuberculosis remains one of the most successful human pathogens. Eight to ten million new cases of active tuberculosis occur each year due in large part to the large reser voir of asymptomatic people chronically infected with M. tuberculosis 1 . Estimates suggest that up to a third of the world's population is latently infected with M. tuberculosis, which indicates that M. tuberculosis can persist over the long term in humans 1 . An understanding of the strategies that M. tuberculosis uses to evade host immunity is essential if an effective vaccine is to be developed 50 . The work reported here has demonstrated that by inhibiting PGE 2 production and apoptosis, M. tuberculosis impairs T cell immunity. Moreover, we have established a direct link between apoptosis of M. tuberculosis-infected macro phages and T cell crosspriming by DCs in vivo. This improved mech anistic understanding might help in optimizing vaccination.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
Note: Supplementary information is available on the Nature Immunology website.
